Nalaganje...
A case report of COVID-19 in refractory myasthenia: Outcome with remdesivir and dexamethasone
RATIONALE: Myasthenia gravis (MG) patients are at increased risk of COVID-19 infection and its complications due to chronic immunosuppression. COVID-19 infection can also increase the risk of myasthenia exacerbation. PATIENT CONCERNS: The patient presented with respiratory distress, fever and chills...
Shranjeno v:
| izdano v: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Lippincott Williams & Wilkins
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8104252/ https://ncbi.nlm.nih.gov/pubmed/33950951 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000025701 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|